EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Acetaminophen Metabolites on Presentation Following an Acute Acetaminophen Overdose ( ATOM ‐7)

Angela L Chiew iD, Geoffrey K Isbister iD, Paul Stathakis, Katherine Z Isoardi iD, Colin Page, Kirsty Ress, Betty S H Chan iD, Nicholas A Buckley iD

Clinical Pharmacology & Therapeutics · 2023-06 · 113 (6) · 1304-1314

DOI: 10.1002/cpt.2888 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 06.04.2023. Verfasst von Angela L Chiew und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Toxicology, Prince of Wales Hospital, Randwick, New South Wales, Australia. Hauptthemen laut MEDLINE: Drug Overdose, Chemical and Drug Induced Liver Injury, Analgesics, Non-Narcotic. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acetaminophen (APAP) is commonly taken in overdose and can cause acute liver injury via the toxic metabolite NAPQI formed by cytochrome (CYP) P450 pathway. We aimed to evaluate the concentrations of APAP metabolites on presentation following an acute APAP poisoning and whether these predicted the subsequent onset of hepatotoxicity (peak alanine aminotransferase > 1,000 U/L). The Australian Toxicology Monitoring (ATOM) study is a prospective observational study, recruiting via two poison information centers and four toxicology units. Patients following an acute APAP ingestion presenting < 24 hours post‐ingestion were recruited. Initial samples were analyzed for APAP metabolites, those measured were the nontoxic glucuronide (APAP‐Glu) and sulfate (APAP‐Sul) conjugates and NAPQI (toxic metabolite) conjugates APAP‐cysteine (APAP‐Cys) and APAP‐mercapturate (APAP‐Mer). The primary outcome was hepatotoxicity. In this study, 200 patients were included, with a median ingested dose of 20 g, 191 received acetylcysteine at median time of 5.8 hours post‐ingestion. Twenty‐six patients developed hepatotoxicity, one had hepatotoxicity on arrival (excluded from analysis). Those who developed hepatotoxicity had significantly higher total CYP metabolite concentrations: (36.8 μmol/L interquartile range (IQR): 27.8–51.7 vs. 10.8 μmol/L IQR: 6.9–19.5) and these were a greater proportion of total metabolites (5.4%, IQR: 3.8–7.7) vs. 1.7%, IQR: 1.3–2.6, P < 0.001)]. Furthermore, those who developed hepatotoxicity had lower APAP‐Sul concentrations (49.1 μmol/L, IQR: 24.7–72.2 vs. 78.7 μmol/L, IQR: 53.6–116.4) and lower percentage of APAP‐Sul (6.3%, IQR: 4.6–10.9 vs. 13.1%, IQR, 9.1–20.8, P < 0.001)]. This study found that those who developed hepatotoxicity had higher APAP metabolites derived from CYP pathway and lower sulfation metabolite on presentation. APAP metabolites may be utilized in the future to identify patients who could benefit from increased acetylcysteine or newer adjunct or research therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug OverdoseChemical and Drug Induced Liver InjuryAnalgesics, Non-NarcoticHumansAcetaminophenAcetylcysteineRetrospective StudiesAustraliaLiverIminesBenzoquinones

Substanzen

AcetaminophenAcetylcysteineAnalgesics, Non-NarcoticN-acetyl-4-benzoquinoneimineIminesBenzoquinones

Autor:innen und Institutionen

  • Department of Clinical Toxicology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
  • Faculty of Medicine, The University of New South Wales, Sydney, New South Wales, Australia.
  • New South Wales Poisons Information Centre, Sydney Children's Hospital, Sydney, New South Wales, Australia.
  • Department of Clinical Toxicology and Pharmacology, Calvary Mater Newcastle and School of Medical Practice, University of Newcastle, Callaghan, New South Wales, Australia.
  • NSW Health Pathology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
  • Clinical Toxicology Unit, Princess Alexandra Hospital, Brisbane, Queensland, Australia.

ORCID-Profile: Angela L Chiew, Geoffrey K Isbister, Katherine Z Isoardi, Betty S H Chan, Nicholas A Buckley

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Chiew, A. L., Isbister, G. K., Stathakis, P., Isoardi, K. Z., Page, C., Ress, K., Chan, B. S. H., & Buckley, N. A. (2023). Acetaminophen Metabolites on Presentation Following an Acute Acetaminophen Overdose ( ATOM ‐7). Clinical Pharmacology & Therapeutics, 113(6), 1304-1314. https://doi.org/10.1002/cpt.2888

Vancouver

Chiew AL, Isbister GK, Stathakis P, Isoardi KZ, Page C, Ress K, et al. Acetaminophen Metabolites on Presentation Following an Acute Acetaminophen Overdose ( ATOM ‐7). Clinical Pharmacology & Therapeutics. 2023;113(6):1304-1314. doi:10.1002/cpt.2888

BibTeX
@article{Chiew2023,
  author = {Chiew, Angela L and Isbister, Geoffrey K and Stathakis, Paul and Isoardi, Katherine Z and Page, Colin and Ress, Kirsty and Chan, Betty S H and Buckley, Nicholas A},
  title = {Acetaminophen Metabolites on Presentation Following an Acute Acetaminophen Overdose ( ATOM ‐7)},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2023},
  volume = {113},
  number = {6},
  pages = {1304--1314},
  doi = {10.1002/cpt.2888}
}
Kostenlos starten →